CID 51060660

N-(2-(2-(1-methyl-3-phenyl-2-propenylidene)hydrazino)-2-oxoethyl)tetradecanamide

Structural Information

Molecular Formula
C26H41N3O2
SMILES
CCCCCCCCCCCCCC(=O)NCC(=O)N/N=C(\C)/C=C/C1=CC=CC=C1
InChI
InChI=1S/C26H41N3O2/c1-3-4-5-6-7-8-9-10-11-12-16-19-25(30)27-22-26(31)29-28-23(2)20-21-24-17-14-13-15-18-24/h13-15,17-18,20-21H,3-12,16,19,22H2,1-2H3,(H,27,30)(H,29,31)/b21-20+,28-23+
InChIKey
YLFNJEBSIXIYSY-QBHFTMPOSA-N
Compound name
N-[2-oxo-2-[(2E)-2-[(E)-4-phenylbut-3-en-2-ylidene]hydrazinyl]ethyl]tetradecanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

427.3199 Da
Monoisotopic Mass

7.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 428.32718 215.2
[M+Na]+ 450.30912 213.5
[M-H]- 426.31262 217.0
[M+NH4]+ 445.35372 224.3
[M+K]+ 466.28306 208.7
[M+H-H2O]+ 410.31716 204.8
[M+HCOO]- 472.31810 236.8
[M+CH3COO]- 486.33375 240.3
[M+Na-2H]- 448.29457 212.2
[M]+ 427.31935 218.6
[M]- 427.32045 218.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.